Pharmafile Logo

Dedicated

- PMLiVE

AstraZeneca announces $15bn investment in Chinese manufacturing and R&D by 2030

The pharma company will be the first global biopharma with end-to-end cell therapy capabilities in China

- PMLiVE

Ipsen appoints Pierrick Lefranc as Executive Vice President Technical Operations

Lefranc has served at Ipsen since 2013, most recently as Senior Vice President

- PMLiVE

Sanofi and Regeneron’s Dupixent receives positive NICE final draft guidance for COPD

Around 1.4 million people in the UK are diagnosed with COPD, with two million thought to be undiagnosed

- PMLiVE

GSK’s Arexvy RSV vaccine receives expanded EC approval for use in adults

RSV affects approximately 64 million people around the world each year

- PMLiVE

Emotive appoints Terri Cooper as chair of the board and Mark Swindell as non-executive director

Terri and Mark both have extensive life sciences and consulting experience

- PMLiVE

ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...

Genesis Research Group

- PMLiVE

Eisai and Biogen’s subcutaneous Leqembi given FDA Priority Review for early Alzheimer’s

Administering the drug subcutaneously rather than intravenously showed similar clinical benefits for patients

- PMLiVE

Gilead’s Trodelvy plus Keytruda shows positive results in metastatic breast cancer

The combination treatment showed a 35% reduction in the risk of disease progression

- PMLiVE

Sanofi’s amlitelimab shows positive results in atopic dermatitis

Newly released study data shows consistent reductions in disease severity

- PMLiVE

Inizio Evoke appoints Kristin Ryan as Executive VP, AI Transformation & Acceleration

Ryan’s most recent role was Executive VP and US Head of Digital & Innovation at GCI Health

- PMLiVE

Novo Nordisk Foundation gives 736m euro grant to Denmark’s BioInnovation Institute

The funding will run until 2035 and will help the organisation to expand its presence in Europe

- PMLiVE

Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026

The PM Awards celebrate creativity in pharmaceutical marketing and healthcare communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links